Medical Science Liaison, Medical Affairs Dept, Promega Corporation
BIOGRAPHY
OCT 26, 2021 9:00 AM PDT
Current Gold-Standards for MSI Testing and the Clinical Relevance of the MSI-H Biomarker
Presented at:
A Microsatellite Instability (MSI) Series
Speaker
Abstract
Dr. Emily Teslow will discuss MSI testing gold standards and compare the different methods that are currently being used for microsatellite instability (MSI) testing for mismatch repair deficient (dMMR) tumors. Then she will discuss the clinical relevance of the MSI-H biomarker focusing on the pathological and epidemiological characteristics of MSI-H/dMMR tumors, and the role of MSI testing in Lynch syndrome screening, colorectal cancer patient prognosis, and immunotherapy treatment.
Learning objectives
- Compare techniques used to measure microsatellite instability to current gold-standard methods
- Discuss the clinical utility of the MSI biomarker for Lynch syndrome screening and immunotherapy treatment
- Review the most current clinical practice guidelines for MSI testing
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
MAY 29, 2024 | 9:00 AM
C.E. CREDITS
Histology laboratorians in the research world move fast, but those who perform cryosectioning know that these particular tissues require lighting speed and precision. Cryosectioning is the a...
MAY 29, 2024 | 8:00 AM
A-TEEM spectroscopy is an emerging technique with huge potential for QC laboratories in the pharmaceutical and biopharmaceutical industries. We present a set of tools for A-TEEM spectroscopy...
JUN 19, 2024 | 8:30 AM
Join us for an illuminating webinar as we delve into the realm of open automation with Inpeco, the global leader in Total Laboratory Automation. Discover how their groundbreaking s...
Loading Comments...